Cochlear Limited (OTCMKTS:CHEOF – Get Free Report) traded up 2.8% on Tuesday. The company traded as high as $94.78 and last traded at $94.62. Approximately 200 shares changed hands during trading, a decline of 85% from the average daily volume of 1,312 shares. The stock had previously closed at $92.00.
Cochlear Stock Performance
The firm’s 50 day moving average is $94.07 and its 200 day moving average is $108.07.
About Cochlear
Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions for people with significant hearing loss. Its products are designed to bypass damaged parts of the ear and stimulate the auditory nerve, helping eligible users perceive sound.
The company’s principal offerings include cochlear implants, sound processors and related accessories, as well as bone-conduction and other implantable hearing systems. Cochlear also provides clinical support, professional services, rehabilitation resources and software intended to help patients and hearing-care professionals manage and optimize these devices.
Cochlear traces its origins to research by Australian scientist Dr.
Featured Articles
- Five stocks we like better than Cochlear
- Phillips 66 Posts Strong Earnings But the Stock Doesn’t Care
- NXP Semiconductors Falls After Strong Earnings—Is the Sell-Off Overdone?
- GE Vernova’s Reservations Are Turning Into Real Orders—But the Market Still Wants More.
- Where’s the Beef? Trian-Led Buyout Proposal Values Wendy’s at $1.4B, But Is It Enough?
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
